ciprofloxacin and Bacterial Infections, Gram-Negative studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Research Excerpts

Excerpt	Relevance	Reference
"In the present study the effect of ciprofloxacin versus ceftazidime on concentrations of pro- and anti-inflammatory cytokines in the sera of patients with severe sepsis was evaluated."	9.11	Comparative effects of ciprofloxacin and ceftazidime on cytokine production in patients with severe sepsis caused by gram-negative bacteria. ( Bassaris, HP; Drosou, E; Gogos, CA; Lekkou, A; Marangos, MN; Skoutelis, A; Starakis, I, 2004)
"To compare meropenem with ciprofloxacin for treatment of gram-negative bacilli sepsis in penicillin-allergic patients in the intensive care unit (ICU) to determine if increased anaphylaxis risk with meropenem precluded its use when weighed against risks of inactive therapy with ciprofloxacin."	8.87	Life-years gained with meropenem over ciprofloxacin in penicillin-allergic patients with gram-negative bacilli sepsis: results of a probabilistic model. ( Bolon, MK; Esterly, JS; Lee, TA; Postelnick, M; Reddy, P; Scheetz, MH, 2011)
"To evaluate the impact of cessation of ciprofloxacin prophylaxis during stem cell transplantation for multiple myeloma."	7.91	Ciprofloxacin prophylaxis during autologous stem cell transplantation for multiple myeloma in patients with a high rate of fluoroquinolone-resistant gram-negative bacteria colonization. ( Gabalec, F; Paterova, P; Radocha, J; Zak, P; Zavrelova, A, 2019)
"The aim of the study was to describe the incidence and type of bacterial infections associated with the use of ciprofloxacin prophylaxis as single agent in pediatric patients with acute myeloid leukemia (AML)."	7.85	Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis. ( Al Omar, S; Al Qasem, W; Anabtawi, N; Rihani, R, 2017)
"We present the results of a protocol of empiric monotherapy of continuous ambulatory peritoneal dialysis (CAPD)-related peritonitis with ciprofloxacin (CPX), with a special emphasis on the evolution of our results after seven years of continued use of this drug."	7.69	Treatment of CAPD-related peritonitis with ciprofloxacin: results after seven years. ( Bouza, P; García Falcón, T; López Vázquez, M; Pérez Fontán, M; Rodríguez-Carmona, A; Tresancos, C; Valdés, F, 1996)
" Ten adverse events were observed in seven patients and in four (7%) of these treatment had to be withdrawn."	6.67	Study of the efficacy and safety of ciprofloxacin in the treatment of chronic sinusitis. ( Barrault, S; Dobler, S; Ebbo, D; Fombeur, JP; Koubbi, G; Laurier, JN; Lecomte, F; Sorrel, N, 1994)
"We report a case of surgical site infection with ciprofloxacin-resistant Aeromonas hydrophila following leech therapy."	5.39	Ciprofloxacin-resistant Aeromonas hydrophila cellulitis following leech therapy. ( Bobenchik, AM; Deville, JG; Giltner, CL; Humphries, RM; Uslan, DZ, 2013)
" After a pre-intervention period, in which cefepime was used as the initial agent for febrile neutropenia, 4 primary antibiotics, namely, piperacillin-tazobactam, ciprofloxacin, meropenem, and cefepime, were rotated at 1-month intervals over 20 months."	5.17	Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity. ( Akashi, K; Chong, Y; Ito, Y; Kamimura, T; Miyamoto, T; Shimoda, S; Shimono, N; Yakushiji, H, 2013)
"In the present study the effect of ciprofloxacin versus ceftazidime on concentrations of pro- and anti-inflammatory cytokines in the sera of patients with severe sepsis was evaluated."	5.11	Comparative effects of ciprofloxacin and ceftazidime on cytokine production in patients with severe sepsis caused by gram-negative bacteria. ( Bassaris, HP; Drosou, E; Gogos, CA; Lekkou, A; Marangos, MN; Skoutelis, A; Starakis, I, 2004)
"A total of 125 ambulatory women (85 premenopausal and 40 postmenopausal) who experienced 174 acute urinary tract infections with mainly gram-negative bacteria (99%) was randomized to receive a single dose, 2-tablet treatment with either ofloxacin (400 mg."	5.07	Single dose quinolone treatment in acute uncomplicated urinary tract infection in women. ( Pfau, A; Sacks, TG, 1993)
"Loperamide decreases the number of unformed stools and shortens the duration of diarrhea in dysentery caused by Shigella in adults treated with ciprofloxacin."	5.07	Ciprofloxacin and loperamide in the treatment of bacillary dysentery. ( Bodhidatta, L; Echeverria, P; Hoge, CW; Imlarp, S; Murphy, GS; Tamura, K; Tansuphaswadikul, S, 1993)
"To compare meropenem with ciprofloxacin for treatment of gram-negative bacilli sepsis in penicillin-allergic patients in the intensive care unit (ICU) to determine if increased anaphylaxis risk with meropenem precluded its use when weighed against risks of inactive therapy with ciprofloxacin."	4.87	Life-years gained with meropenem over ciprofloxacin in penicillin-allergic patients with gram-negative bacilli sepsis: results of a probabilistic model. ( Bolon, MK; Esterly, JS; Lee, TA; Postelnick, M; Reddy, P; Scheetz, MH, 2011)
" The vast majority of Enterobacteriaceae, including ESBL producers, remain susceptible to carbapenems, and these agents are considered preferred empiric therapy for serious Enterobacteriaceae infections."	4.83	Resistance in gram-negative bacteria: enterobacteriaceae. ( Paterson, DL, 2006)
"To evaluate the impact of cessation of ciprofloxacin prophylaxis during stem cell transplantation for multiple myeloma."	3.91	Ciprofloxacin prophylaxis during autologous stem cell transplantation for multiple myeloma in patients with a high rate of fluoroquinolone-resistant gram-negative bacteria colonization. ( Gabalec, F; Paterova, P; Radocha, J; Zak, P; Zavrelova, A, 2019)
"The aim of the study was to describe the incidence and type of bacterial infections associated with the use of ciprofloxacin prophylaxis as single agent in pediatric patients with acute myeloid leukemia (AML)."	3.85	Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis. ( Al Omar, S; Al Qasem, W; Anabtawi, N; Rihani, R, 2017)
" The majority of gram-negative bacterial infections were multidrug resistant, but 17 of the 20 gram-negative bacteria were sensitive to meropenem."	3.81	Bacteria causing ventriculoperitoneal shunt infections in a Kenyan population. ( Albright, AL; Ferson, S; Ochieng', N; Okechi, H, 2015)
" Both he and his partner were treated with oral ciprofloxacin 500 mg bd for 6 weeks with clinical clearance of infection, but both developed a scarring alopecia."	3.74	A possible new cause of spa bath folliculitis: Aeromonas hydrophila. ( Mulholland, A; Yong-Gee, S, 2008)
" We evaluated retrospectively the effect of antibiotic prophylaxis with ciprofloxacin and penicillin on the prevention of bacterial infections in 112 cases of prolonged neutropenia in adult patients treated for haematological malignancies."	3.70	[Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies]. ( Baumgartner, JD; Cometta, A; Delarive, P; Glauser, MP, 2000)
"We describe a 66-year-old woman with infective endocarditis due to Cardiobacterium hominis whose condition, complicated by severe aortic regurgitation and congestive heart failure, necessitated aortic valve replacement despite treatment with ceftriaxone followed by ciprofloxacin."	3.70	Infective endocarditis complicated with progressive heart failure due to beta-lactamase-producing Cardiobacterium hominis. ( Hsueh, PR; Hung, CC; Jang, TN; Lu, PL; Luh, KT; Teng, LJ, 2000)
" In the UK chloramphenicol is commonly recommended as the drug of first choice for the treatment of superficial bacterial eye infections."	3.69	Fluoroquinolones for the eye. ( , 1994)
"Ciprofloxacin may be considered as first-line treatment for a number of infections in which gram-negative pathogens are proven or strongly suspected, including complicated urinary tract infections, bacterial prostatitis, bacterial diarrhea, selected bone and joint infections, malignant otitis externa, bronchopulmonary infections in patients with cystic fibrosis and selected pneumonia cases."	3.69	Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society. ( Louie, TJ, 1994)
"We present the results of a protocol of empiric monotherapy of continuous ambulatory peritoneal dialysis (CAPD)-related peritonitis with ciprofloxacin (CPX), with a special emphasis on the evolution of our results after seven years of continued use of this drug."	3.69	Treatment of CAPD-related peritonitis with ciprofloxacin: results after seven years. ( Bouza, P; García Falcón, T; López Vázquez, M; Pérez Fontán, M; Rodríguez-Carmona, A; Tresancos, C; Valdés, F, 1996)
" Currently, its use is off-label partly because of lack of pharmacokinetic studies."	2.79	Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age. ( Castellan, C; Hill, H; Jacqz-Aigrain, E; Kassai, B; Kearns, GL; Le Guellec, C; Mahoney, S; Neal, T; Paulus, S; Turner, MA; van den Anker, JN; Zhao, W, 2014)
"ciprofloxacin was at least equivalent to imipenem in terms of bacteriological eradication and clinical response."	2.69	Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia. ( Caldwell, JW; Johnson, RH; Singh, S, 1999)
" The mean bioavailability of enteral dosing was 53."	2.69	Bioavailability of ciprofloxacin after multiple enteral and intravenous doses in ICU patients with severe gram-negative intra-abdominal infections. ( Bruining, HA; Buijk, SL; de Marie, S; Kluytmans, JA; Mouton, JW; van Vliet, A; VandenBergh, MF, 1998)
" Ten adverse events were observed in seven patients and in four (7%) of these treatment had to be withdrawn."	2.67	Study of the efficacy and safety of ciprofloxacin in the treatment of chronic sinusitis. ( Barrault, S; Dobler, S; Ebbo, D; Fombeur, JP; Koubbi, G; Laurier, JN; Lecomte, F; Sorrel, N, 1994)
"Ciprofloxacin/metronidazole was more cost-effective compared with piperacillin/tazobactam (2200 US dollars-3600 US dollars lower cost-effective ratios per patient) regardless of whether the patient had a diagnosis of appendicitis or whether a switch to an oral drug was permissible."	2.42	Use of ciprofloxacin in the treatment of hospitalized patients with intra-abdominal infections. ( Madan, AK, 2004)
"We report a case of Eikenella discitis occurring soon after spinal surgery in an otherwise healthy patient, review the literature on bone and joint infections unrelated to human bites and fist-fight injuries, and stress the importance of definitive diagnosis in post-operative spinal infections."	2.41	Eikenella corrodens discitis after spinal surgery: case report and literature review. ( Ang, BS; Ngan, CC, 2002)
"Ciprofloxacin was the most prescribed oral antibiotic (53%)."	1.72	Intravenous to oral transition of antibiotics for gram-negative bloodstream infection at a University hospital in Thailand: Clinical outcomes and predictors of treatment failure. ( Gross, AE; Nakaranurack, C; Pradubkham, T; Suwanpimolkul, G, 2022)
"Plague is a life-threatening disease caused by the bacterium, Yersinia pestis."	1.48	Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report. ( Andrianaivoarimanana, V; Bertherat, E; Rajaonarison, R; Rajerison, M; Rakotondramaro, T; Rogier, C, 2018)
" Ciprofloxacin dosed in identical fashion displayed rapid clearance with a half-life of approximately 30 min."	1.48	Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections. ( Chen, J; Convertine, AJ; Lee, B; Ratner, DM; Skerrett, SJ; Srinivasan, S; Stayton, PS; Su, FY; West, TE, 2018)
"Ciprofloxacin treatment exhibited an independent protective effect (adjusted hazard ratio (aHR) 0."	1.40	Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study. ( Ariza, J; Bahamonde, A; Baraia-Etxaburu, JM; Benito, N; Cobo, J; Corona, PS; del Toro, MD; Euba, G; Fernández-Sampedro, M; Flores-Sánchez, X; Guio, L; Iribarren, JA; Lora-Tamayo, J; Palomino, J; Pigrau, C; Ramos, A; Riera, M; Rodríguez-Pardo, D; Sánchez-Somolinos, M; Soriano, A; Sorli, L, 2014)
"We present a unique case of acute bacterial prostatitis caused by a very rare human pathogen, Raoultella planticola, in a renal allograft recipient 3."	1.40	Acute prostatitis caused by Raoultella planticola in a renal transplant recipient: a novel case. ( Bakalis, A; Belesiotou, E; Drakopoulos, S; Kalatzis, V; Koukoulaki, M; Papastamopoulos, V; Skoutelis, A, 2014)
"Linezolid was selected as a first-line antimicrobial drug."	1.39	Otogenic cerebellar abscess by Enterococcus avium, a very rare infectious agent. ( Escribano, JA; Lozano, J; Rivin, E; Solivera, J; Vidal, E, 2013)
"We report a case of surgical site infection with ciprofloxacin-resistant Aeromonas hydrophila following leech therapy."	1.39	Ciprofloxacin-resistant Aeromonas hydrophila cellulitis following leech therapy. ( Bobenchik, AM; Deville, JG; Giltner, CL; Humphries, RM; Uslan, DZ, 2013)
"Gatifloxacin showed lower resistance levels than moxifloxacin."	1.38	[In vitro antibiotic susceptibility to fluoroquinolones]. ( Galvis, V; Rey, JJ; Tello, A; Villareal, D; Wong, CA, 2012)
"A population pharmacokinetic model was first developed on ciprofloxacin serum concentrations obtained in 102 ICU patients."	1.37	Optimizing ciprofloxacin dosing in intensive care unit patients through the use of population pharmacokinetic-pharmacodynamic analysis and Monte Carlo simulations. ( Conil, JM; Georges, B; Houin, G; Khachman, D; Laffont, CM; Saivin, S; Toutain, PL, 2011)
"Paronychia is a well-known, but difficult to treat cutaneous toxicity associated with epidermal growth factor receptor (EGFR) inhibitor therapy."	1.36	Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia. ( Eames, T; Grabein, B; Kroth, J; Wollenberg, A, 2010)
"Peritonitis is a major cause of morbidity in continuous ambulatory peritoneal dialysis (CAPD)."	1.36	Quinolone-resistant Aeromonas hydrophila peritonitis in a CAPD patient. ( Barut, HS; Sahin, I, 2010)
"Ertapenem and imipenem were the most active drugs tested, inhibiting over 90% of all species, including ESBL-positive isolates with the exception of Pseudomonas aeruginosa isolates (<90% susceptible to all study drugs) and ESBL-positive Klebsiella pneumoniae isolates (<90% susceptible to all study drugs except imipenem)."	1.35	Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. ( Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ; Hsueh, PR; Paterson, DL, 2009)
"Moxifloxacin is a respiratory fluoroquinolone with a community acquired pneumonia indication."	1.35	Fluoroquinolone resistance during 2000-2005: an observational study. ( Lindsell, C; Ryan, RJ; Sheehan, P, 2008)
"Ciprofloxacin-untreated rats exhibited a predominantly gram-negative polymicrobial sepsis."	1.34	Plasma thrombin activatable fibrinolysis inhibitor and tissue factor pathway inhibitor changes following sepsis. ( Fareed, J; Florian-Kujawski, M; Goto, M; Hammadeh, R; Hoppensteadt, D; Iqbal, O; Ravindranath, TM; Sayeed, MM, 2007)
"An 81-year-old man developed septic arthritis and bacteraemia with Aeromonas veronii biovar sobria."	1.33	Aeromonas veronii biovar sobria bacteraemia with septic arthritis confirmed by 16S rDNA PCR in an immunocompetent adult. ( Enoch, DA; Harris, KA; Karas, JA; Roberts, MTM, 2006)
" Urine samples were taken every 2 h during the whole dosing interval of the particular antibiotic."	1.33	Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model. ( Bedenic, B; Bubonja, M; Budimir, A; Topic, M, 2006)
"Ciprofloxacin resistance was more frequent in children who shared an environment with adults who were receiving ciprofloxacin prophylaxis."	1.33	Differences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two Italian centres. ( Castagnola, E; Caviglia, I; Giona, F; Girmenia, C; Haupt, R; Micozzi, A; Parodi, S; Testi, AM, 2005)
" pneumoniae, MPC results were below susceptible breakpoints and within clinically achievable and sustainable drug concentrations for >24 hours of the dosing interval against."	1.33	Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens. ( Blondeau, JM; Hansen, GT, 2005)
"Severe thrombocytopenia is a life-threatening condition."	1.32	Cardiobacterium hominis endocarditis associated with very severe thrombocytopenia and platelet autoantibodies. ( Arnold, DM; Christjanson, L; Smaill, F; Walker, I; Warkentin, TE, 2004)
"A patient with chronic lymphocytic leukemia developed a cutaneous infection with the clinical pattern of necrotizing otitis externa."	1.32	[Necrotizing otitis externa caused by Stenotrophomonas maltophilia]. ( Börner, D; Fischer, M; Marsch, WC, 2003)
"Rhinoscleroma is a very rare cause of upper airway obstruction with only isolated reports in the literature of rhinoscleroma with isolated tracheal obstruction."	1.31	Upper airway obstruction due to rhinoscleroma: case report. ( Al Jahdali, H; Al Othman, A; Al-Zuwayed, M; Bamefleh, H; Memish, Z, 2001)
"Ciprofloxacin was also tested against Gram-negative isolates."	1.31	Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections. ( Bartizal, K; Gesser, RM; Motyl, M; Pelak, BA; Woods, GL, 2002)
"Ciprofloxacin was the most potent study drug against the family of Enterobacteriaceae and Pseudomonas spp."	1.30	Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests. ( Barry, AL; Brown, SD; Fuchs, PC, 1999)
"Moxifloxacin was eight- to 32-fold more potent than ciprofloxacin and ofloxacin against staphylococci and Streptococcus pneumoniae, and equivalent to eight-fold more potent against enterococci."	1.30	Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin. ( Chartrand, SA; Moland, ES; Pong, A; Sanders, CC; Thomson, KS, 1999)
"Neutropenia was less severe (P < 0."	1.29	Prevention of bacteraemia by systemic ciprofloxacin treatment in rat cytomegalovirus-infected immunocompromised rats. ( Bruggeman, CA; Stals, FS; vd Bogaard, AE, 1994)
"Amikacin and imipenem were the agents most active against the 33,869 nonduplicate isolates (those recovered only once) tested."	1.29	Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. ( Bell-Dixon, C; Itokazu, GS; Kahan, FM; Quinn, JP; Weinstein, RA, 1996)
" Given the disparity among various in vitro susceptibility methods, this study incorporated a unique pharmacodynamic model to more accurately characterize the bacterial time-kill curves and mutation rates of four clinical isolates of S."	1.29	Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. ( Anderson, DE; Anderson, JD; Campbell, DM; Carroll, KC; Garrison, MW; Hollis, RJ; Malone, CL; Pfaller, MA, 1996)
"Ciprofloxacin was administered intravenously to six ponies at a dose of 5 mg per kg body weight."	1.29	Pharmacokinetics of ciprofloxacin in ponies. ( Dowling, PM; Duran, SH; Tyler, JW; Wilson, RC, 1995)
"Treatment with ciprofloxacin appeared to accelerate recovery from severe or persistent diarrhoea due to this organism."	1.28	Treatment of symptomatic enteric aeromonas hydrophila infection with ciprofloxacin. ( Harvey, G; Laing, RB; Nathwani, D; Smith, CC, 1991)

Research

Studies (231)

Authors

Clinical Trials (8)

Trial Overview

Trial Outcomes

Number of Participants With Combination of Gastrointestinal Tract Colonization With Multi-drug Resistant Gram-negative Bacteria, C. Difficile and VRE

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	53 (22.94)	18.2507
2000's	81 (35.06)	29.6817
2010's	87 (37.66)	24.3611
2020's	10 (4.33)	2.80

Authors	Studies
Morio, F	1
Jean-Pierre, H	1
Dubreuil, L	1
Jumas-Bilak, E	1
Calvet, L	1
Mercier, G	1
Devine, R	1
Marchandin, H	1
Zhanel, GG	1
DeCorby, M	1
Laing, N	1
Weshnoweski, B	1
Vashisht, R	1
Tailor, F	1
Nichol, KA	1
Wierzbowski, A	1
Baudry, PJ	1
Karlowsky, JA	1
Lagacé-Wiens, P	1
Walkty, A	1
McCracken, M	1
Mulvey, MR	1
Johnson, J	1
Hoban, DJ	2
Liu, CY	1
Huang, YT	1
Liao, CH	1
Hsueh, PR	4
Sánchez-Céspedes, J	1
Blasco, MD	1
Marti, S	1
Alba, V	1
Alcalde, E	1
Esteve, C	1
Vila, J	1
Amsler, KM	1
Davies, TA	1
Shang, W	1
Jacobs, MR	1
Bush, K	1
Shimizu, K	1
Kikuchi, K	1
Sasaki, T	1
Takahashi, N	1
Ohtsuka, M	1
Ono, Y	1
Hiramatsu, K	1
Rossolini, GM	1
Luzzaro, F	1
Migliavacca, R	1
Mugnaioli, C	1
Pini, B	1
De Luca, F	1
Perilli, M	1
Pollini, S	1
Spalla, M	1
Amicosante, G	1
Toniolo, A	1
Pagani, L	1
Hawser, SP	1
Bouchillon, SK	1
Badal, RE	1
Paterson, DL	2
Hsu, LY	1
Tan, TY	1
Tam, VH	1
Kwa, A	1
Fisher, DA	1
Koh, TH	1
Makawana, JA	1
Mungra, DC	1
Patel, MP	1
Patel, RG	1
Montgomery, JI	1
Brown, MF	1
Reilly, U	1
Price, LM	1
Abramite, JA	1
Arcari, J	1
Barham, R	1
Che, Y	1
Chen, JM	1
Chung, SW	1
Collantes, EM	1
Desbonnet, C	1
Doroski, M	1
Doty, J	1
Engtrakul, JJ	1
Harris, TM	1
Huband, M	1
Knafels, JD	1
Leach, KL	1
Liu, S	1
Marfat, A	1
McAllister, L	1
McElroy, E	1
Menard, CA	1
Mitton-Fry, M	1
Mullins, L	1
Noe, MC	1
O'Donnell, J	1
Oliver, R	1
Penzien, J	1
Plummer, M	1
Shanmugasundaram, V	1
Thoma, C	1
Tomaras, AP	1
Uccello, DP	1
Vaz, A	1
Wishka, DG	1
Mohammed, JM	1
Sajana, TM	1
Raj, R	1
Rachana, BA	1
Paul, G	1
Pillai, PR	1
Li, LH	1
Lu, HF	1
Liu, YF	1
Lin, YT	1
Yang, TC	1
Pradubkham, T	1
Suwanpimolkul, G	1
Gross, AE	1
Nakaranurack, C	1
Chatree, Y	1
Charoenlap, N	1
Vanitshavit, V	1
Ruangrassamee, P	1
Mongkolsuk, S	1
Vattanaviboon, P	1
Yu, S	1
Wang, S	1
Zou, P	1
Chai, G	1
Lin, YW	1
Velkov, T	1
Li, J	1
Pan, W	1
Zhou, QT	1
Dilhari, A	1
Pathirage, S	1
Gunasekara, C	1
Fernando, N	1
Weerasekara, D	1
McBain, A	1
Weerasekera, M	1
Valéry, M	1
Bourrel, AS	1
Grignano, E	1
Kernéis, S	1
Contejean, A	1
Siebert, C	1
Villers, C	1
Pavlou, G	1
Touquet, B	1
Yakandawala, N	1
Tardieux, I	1
Renesto, P	1
Hao, Y	1
Chen, S	1
Chang, H	1
Yan, X	1
Zhou, W	1
Cao, X	1
Huang, R	1
Zhang, Z	1
Zhang, H	1
Jia, B	1
Wu, W	1
Xiong, Y	1
Chen, Y	2
Wu, C	2
Vidal-Veuthey, B	1
Jara, R	1
Santander, K	1
Mella, A	1
Ruiz, S	1
Collado, L	1
Miyamoto, Y	1
Udaka, K	1
Sekimoto, E	1
Shibata, H	1
Otsuka, K	1
Mori, K	1
Shigekiyo, T	1
Ozaki, S	1
Wattier, RL	1
Levy, ER	1
Sabnis, AJ	1
Dvorak, CC	1
Auerbach, AD	1
Matsuura, N	1
Miyoshi, M	1
Doi, N	1
Yagi, S	1
Aradono, E	1
Imamura, T	1
Koga, R	1
Chang, J	1
Xu, Z	1
Wang, Z	2
Zeng, Q	1
Fan, H	1
Varo, R	1
Sitoe, A	1
Cossa, A	1
Ordi, J	1
Rozman, M	1
Bassat, Q	1
Palioura, S	1
Gibbons, A	1
Miller, D	2
OʼBrien, TP	1
Alfonso, EC	2
Spierer, O	1
Bianco, G	1
Boattini, M	1
Audisio, E	1
Cavallo, R	1
Costa, C	1
Hamed, SM	1
Aboshanab, KMA	1
El-Mahallawy, HA	1
Helmy, MM	1
Ashour, MS	1
Elkhatib, WF	1
Frawley, AA	1
Powell, L	1
McQuiston, JR	1
Gulvik, CA	1
Bégué, RE	1
Poore, TS	1
Virella-Lowell, I	1
Guimbellot, JS	1
Andrianaivoarimanana, V	1
Bertherat, E	1
Rajaonarison, R	1
Rakotondramaro, T	1
Rogier, C	1
Rajerison, M	1
Su, FY	1
Srinivasan, S	1
Lee, B	1
Chen, J	1
Convertine, AJ	1
West, TE	1
Ratner, DM	1
Skerrett, SJ	1
Stayton, PS	1
Zavrelova, A	1
Paterova, P	1
Gabalec, F	1
Zak, P	1
Radocha, J	1
Villaverde González, S	1
Eugenieva Marinova, F	1
Rasines Rodríguez, A	1
Orden Martínez, B	1
Golmayo Gaztelu, L	1
Saez Nieto, JA	1
Cilleruelo Ortega, MJ	1
Tokatly Latzer, I	1
Nahum, E	1
Cavari, Y	1
Lazar, I	1
Ben-Ari, Y	1
Ben-Shimol, S	1
Ben-Shalom, G	1
Geffen, Y	1
Goldberg, L	1
Rubinstein, M	1
Keller, N	1
Pessach, IM	1
Paret, G	1
Luna, BM	1
Ershova, K	1
Yan, J	1
Ulhaq, A	1
Nielsen, TB	1
Hsieh, S	1
Pantapalangkoor, P	1
Vanscoy, B	1
Ambrose, P	1
Rudin, S	1
Hujer, K	1
Bonomo, RA	1
Actis, L	1
Skaar, EP	1
Spellberg, B	1
Wilmer, A	1
Slater, K	1
Yip, J	1
Carr, N	1
Grant, J	1
Escribano, JA	1
Solivera, J	1
Vidal, E	1
Rivin, E	1
Lozano, J	1
Dabkowski, J	1
Dodds, P	1
Hughes, K	1
Bush, M	1
Graham, SM	1
Fishlock, A	1
Millner, P	1
Sandoe, J	1
Pence, MA	1
Sharon, J	1
McElvania Tekippe, E	1
Pakalniskis, BL	1
Ford, BA	1
Burnham, CA	1
Fatima, A	1
Afridi, FI	1
Qureshi, A	1
Farooqi, BJ	1
Hussain, A	1
Blennow, O	1
Ljungman, P	1
Sparrelid, E	1
Mattsson, J	1
Remberger, M	1
van Alphen, NA	1
Gonzalez, A	1
McKenna, MC	1
McKenna, TK	1
Carlsen, BT	1
Moran, SL	1
Dobiasova, H	1
Kutilova, I	1
Piackova, V	1
Vesely, T	1
Cizek, A	1
Dolejska, M	1
Koukoulaki, M	1
Bakalis, A	1
Kalatzis, V	1
Belesiotou, E	1
Papastamopoulos, V	1
Skoutelis, A	2
Drakopoulos, S	1
Rodríguez-Pardo, D	1
Pigrau, C	1
Lora-Tamayo, J	1
Soriano, A	1
del Toro, MD	1
Cobo, J	1
Palomino, J	1
Euba, G	1
Riera, M	1
Sánchez-Somolinos, M	1
Benito, N	1
Fernández-Sampedro, M	1
Sorli, L	1
Guio, L	1
Iribarren, JA	1
Baraia-Etxaburu, JM	1
Ramos, A	1
Bahamonde, A	1
Flores-Sánchez, X	1
Corona, PS	1
Ariza, J	1
Zhao, W	1
Hill, H	1
Le Guellec, C	1
Neal, T	1
Mahoney, S	1
Paulus, S	1
Castellan, C	1
Kassai, B	1
van den Anker, JN	1
Kearns, GL	1
Turner, MA	1
Jacqz-Aigrain, E	1
Wong, PH	1
von Krosigk, M	1
Roscoe, DL	1
Lau, TT	1
Yousefi, M	1
Bowie, WR	1
Ochieng', N	1
Okechi, H	1
Ferson, S	1
Albright, AL	1
Sand, D	1
She, R	1
Shulman, IA	1
Chen, DS	1
Schur, M	1
Hsu, HY	1
Li, L	1
Tarrand, JJ	1
Han, XY	1
Guo, W	1
He, Q	1
Wei, M	1
Yang, Z	1
Du, Y	1
He, J	1
Card, RM	1
Mafura, M	1
Hunt, T	1
Kirchner, M	1
Weile, J	1
Rashid, MU	1
Weintraub, A	1
Nord, CE	1
Anjum, MF	1
Calzada, M	1
Roig, M	1
Martínez-Toldos, MC	1
Segovia, M	1
Shirzad Aski, H	1
Tabatabaei, M	1
Khoshbakht, R	1
Raeisi, M	1
Decroix, V	1
Pluquet, E	1
Choquet, M	1
Ammenouche, N	1
Castelain, S	1
Guiheneuf, R	1
Chanyi, RM	1
Koval, SF	1
Brooke, JS	1
Rajchgot, J	1
Glicksman, R	1
Bogoch, II	1
Morganti, L	1
Córdova, E	1
Cassini, E	1
Gómez, N	1
López Moral, L	1
Badía, M	1
Rodríguez, C	1
Langford, BJ	1
Seah, J	1
Chan, A	1
Downing, M	1
Johnstone, J	1
Matukas, LM	1
Usarek, P	1
Dobrzaniecka, K	1
Szymanek-Majchrzak, K	1
Sawicka-Grzelak, A	1
Mlynarczyk, A	1
Durlik, M	1
Ciszek, M	1
Paczek, L	1
Chmura, A	1
Kwiatkowski, A	1
Mlynarczyk, G	1
Margaritis, A	1
Galani, I	1
Chatzikonstantinou, M	1
Petrikkos, G	1
Souli, M	1
Olszewski, AE	1
Karandikar, MV	1
Surana, NK	1
Ullah, O	1
Khan, A	1
Ambreen, A	1
Ahmad, I	1
Akhtar, T	1
Gandapor, AJ	1
Khan, AM	1
Al Omar, S	1
Anabtawi, N	1
Al Qasem, W	1
Rihani, R	1
Domosławska, A	1
Zduńczyk, S	1
Jurczak, A	1
Janowski, T	1
Nazik, H	1
Ongen, B	1
Kuvat, N	1
Reddy, AK	1
Murthy, SI	1
Jalali, S	1
Gopinathan, U	1
Aubert, T	1
Rovery, C	1
Bourhaba, K	1
Singeorzan, S	1
Heim, M	1
Crétel, E	1
Battaglia, TC	1
Lim, IW	1
Stride, PJ	1
Horvath, RL	1
Hamilton-Craig, CR	1
Chau, PP	1
Passerini de Rossi, B	1
García, C	1
Calenda, M	1
Vay, C	2

Trial	Phase	Enrollment	Study Type	Start Date	Status
Population Pharmacokinetics of Anti-infective Drugs in Children in Anti-infectious Therapies[NCT03113344]		800 participants (Anticipated)	Observational [Patient Registry]	2017-06-21	Recruiting
Population Pharmacokinetics of Meropenem and Linezolid in Children With Severe Infectious Diseases[NCT03643497]		800 participants (Anticipated)	Observational [Patient Registry]	2018-07-01	Recruiting
Antimicrobial Resistance Profiles in Healthcare Facilities From Meta State, Colombia: A Retrospective Observational Study From 2018-2022[NCT06044272]		10,000 participants (Anticipated)	Observational	2023-09-30	Not yet recruiting
Impact of Selective Reporting of Antibiotic Susceptibility Test Results in Urinary Tract Infections in the Outpatient Setting: a Protocol for a Pragmatic, Prospective Quasi-experimental Trial[NCT03612297]		64,000 participants (Anticipated)	Observational	2018-09-01	Not yet recruiting
The Use of the Probiotic, Lactobacillus Rhamnosus GG to Evaluate Colonization With Antimicrobial Resistant Bacteria in High Risk Patients[NCT01551186]	Phase 4	103 participants (Actual)	Interventional	2012-02-29	Completed
Impact of the Duration of Antibiotics on Clinical Events in Patients With Pseudomonas Aeruginosa Ventilator-associated Pneumonia : a Randomized Controlled Study (iDIAPASON)[NCT02634411]		190 participants (Actual)	Interventional	2016-06-03	Completed
Randomized Trial of Standard vs. Enhanced Hydration in Patients With a Diagnosis of Acute Pancreatitis Within the First Hour of the Diagnosis[NCT02709044]	Phase 2/Phase 3	903 participants (Anticipated)	Interventional	2016-02-29	Recruiting
Contribution of Fast Molecular Bacterial Identification by Real-time PCR in Managing of Postoperative Acute Endophthalmitis[NCT02850653]		150 participants (Anticipated)	Interventional	2007-11-30	Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Colonization of the gastrointestinal tract with C. difficile, vancomycin-resistant enterococci, multidrug-resistant Acinetobacter baumannii, and multidrug- resistant Pseudomonas. Colonization occurs when the subject acquires the above organism while in the study. (NCT01551186)
Timeframe: Participants will be followed while Intubated, an expected average of 7 days. The outcome will be measured 3 days after enrollment and at the end of intubation, average time 7 days)

Reviews

Trials

Other Studies

195 other studies available for ciprofloxacin and Bacterial Infections, Gram-Negative

Article	Year
Hematopoietic neoplasms accompanied by severe enterocolitis due to Aeromonas species. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2017, Volume: 58, Issue:4 Topics: Aeromonas; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Ciprofloxacin; Diarrhea; Enterocoliti	2017
Aeromonas as a Cause of Purulent Folliculitis: A Case Report and Review of the Literature. Journal of the Pediatric Infectious Diseases Society, 2017, Mar-01, Volume: 6, Issue:1 Topics: Aeromonas; Breast Diseases; Child; Ciprofloxacin; Dominican Republic; Female; Folliculitis; Gram-Neg	2017
Life-years gained with meropenem over ciprofloxacin in penicillin-allergic patients with gram-negative bacilli sepsis: results of a probabilistic model. Pharmacotherapy, 2011, Volume: 31, Issue:5 Topics: Anaphylaxis; Anti-Bacterial Agents; Ciprofloxacin; Decision Trees; Drug Hypersensitivity; Gram-Negat	2011
Inhaled antibiotics in cystic fibrosis: what's new? Journal of the Royal Society of Medicine, 2012, Volume: 105 Suppl 2 Topics: Administration, Inhalation; Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Child; Child, Pr	2012
Peritonitis caused by Roseomonas in a patient undergoing automated peritoneal dialysis: case report and literature review. Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:13 Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Female; Gentamicins; Gram-Negative Bacterial Infections;	2012
Ciprofloxacin-resistant Aeromonas hydrophila infection following leech therapy: a case report and review of the literature. Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2013, Volume: 66, Issue:1 Topics: Aeromonas hydrophila; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aztreonam; Ciprofloxacin; Drug	2013
Eikenella corrodens discitis after spinal surgery: case report and literature review. The Journal of infection, 2002, Volume: 45, Issue:4 Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Discitis; Eikenella corrodens; Gram-Negative Bacterial	2002
Microbial keratitis and vision loss with contact lenses. Eye & contact lens, 2003, Volume: 29, Issue:1 Suppl Topics: Adult; Alcaligenes; Anti-Infective Agents; Ciprofloxacin; Contact Lenses, Extended-Wear; Corneal Ulc	2003
Ciprofloxacin extended release: in the treatment of urinary tract infections and uncomplicated pyelonephritis. Drugs & aging, 2004, Volume: 21, Issue:1 Topics: Administration, Oral; Anti-Bacterial Agents; Ciprofloxacin; Delayed-Action Preparations; Gram-Negati	2004
Use of ciprofloxacin in the treatment of hospitalized patients with intra-abdominal infections. Clinical therapeutics, 2004, Volume: 26, Issue:10 Topics: Abdominal Abscess; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Gram-Negative Ba	2004
Resistance in gram-negative bacteria: enterobacteriaceae. The American journal of medicine, 2006, Volume: 119, Issue:6 Suppl 1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Ciprofloxacin; Community-	2006
[Bacteria of the genus Arcobacter, a new etiological factor of nosocomial infections]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2006, Volume: 51, Issue:2 Topics: Animals; Arcobacter; Bacteriological Techniques; Ciprofloxacin; Cross Infection; Erythromycin; Gram-	2006
Quinolone therapy in intensive care unit settings. New horizons (Baltimore, Md.), 1993, Volume: 1, Issue:2 Topics: Administration, Oral; Aged; Ciprofloxacin; Clinical Protocols; Clinical Trials as Topic; Cross Infec	1993
Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy. Connecticut medicine, 1993, Volume: 57, Issue:8 Topics: Administration, Oral; Anti-Bacterial Agents; Ciprofloxacin; Drug Costs; Drug Tolerance; Female; Fluo	1993
Rahnella aquatilis bacteremia in an HIV-infected intravenous drug abuser. Diagnostic microbiology and infectious disease, 1995, Volume: 22, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Gram-Ne	1995
Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine, 1997, Volume: 76, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Breast Neoplasms; Ciprofloxacin; Dr	1997

Article	Year
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9 Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bac	2008
Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11 Topics: Anti-Bacterial Agents; Area Under Curve; Body Weight; Cardiotonic Agents; Chromatography, High Press	2014
Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11 Topics: Anti-Bacterial Agents; Area Under Curve; Body Weight; Cardiotonic Agents; Chromatography, High Press	2014
Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11 Topics: Anti-Bacterial Agents; Area Under Curve; Body Weight; Cardiotonic Agents; Chromatography, High Press	2014
Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11 Topics: Anti-Bacterial Agents; Area Under Curve; Body Weight; Cardiotonic Agents; Chromatography, High Press	2014
Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity. PloS one, 2013, Volume: 8, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cefepime;	2013
Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology, 2004, Volume: 126, Issue:4 Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Female; Gram-Negative Bacter	2004
Comparative effects of ciprofloxacin and ceftazidime on cytokine production in patients with severe sepsis caused by gram-negative bacteria. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:8 Topics: Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Cytokines; Female; G	2004
Clinical effect of intravenous ciprofloxacin on hospital-acquired pneumonia. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2005, Volume: 11, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bac	2005
Short-term antibiotic prophylaxis in implant surgery: a comparison of three antibiotics. The Nigerian postgraduate medical journal, 2007, Volume: 14, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftriaxone; Cefuroxime; Cip	2007
Study of the efficacy and safety of ciprofloxacin in the treatment of chronic sinusitis. Chemotherapy, 1994, Volume: 40 Suppl 1 Topics: Adult; Chronic Disease; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Gram-Positive Bac	1994
Single dose quinolone treatment in acute uncomplicated urinary tract infection in women. The Journal of urology, 1993, Volume: 149, Issue:3 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Female; Gram-Negative Bacterial Infect	1993
Ciprofloxacin and loperamide in the treatment of bacillary dysentery. Annals of internal medicine, 1993, Apr-15, Volume: 118, Issue:8 Topics: Adult; Ciprofloxacin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Dysentery, Bacillary	1993
Discontinuation of intravenous antibiotic therapy during persistent neutropenia in patients receiving prophylaxis with oral ciprofloxacin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 21, Issue:5 Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fever of Unknown	1995
Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis. Clinical nephrology, 1997, Volume: 48, Issue:6 Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Com	1997
Bioavailability of ciprofloxacin after multiple enteral and intravenous doses in ICU patients with severe gram-negative intra-abdominal infections. Intensive care medicine, 1998, Volume: 24, Issue:4 Topics: Adult; Aged; Anti-Infective Agents; Biological Availability; Ciprofloxacin; Creatinine; Critical Car	1998
Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia. The Journal of antimicrobial chemotherapy, 1999, Volume: 43 Suppl A Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cost-Benefit Analysis; Cross Infection; Double-Blind Me	1999
Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study. Journal of hepatology, 2000, Volume: 33, Issue:4 Topics: Administration, Oral; Analysis of Variance; Anti-Infective Agents; Ascitic Fluid; Ciprofloxacin; Cre	2000
Oral fluoroquinolone therapy results in drug adsorption on ureteral stents and prevention of biofilm formation. International journal of antimicrobial agents, 2001, Volume: 17, Issue:4 Topics: Administration, Oral; Adsorption; Anti-Infective Agents; Anti-Infective Agents, Urinary; Biofilms; C	2001
Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabetic medicine : a journal of the British Diabetic Association, 2001, Volume: 18, Issue:10 Topics: Adult; Bacterial Infections; Biopsy; Ciprofloxacin; Clindamycin; Corynebacterium; Diabetic Foot; Dru	2001
Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:4-5 Topics: Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Ciprofloxacin; Colistin; Drug Therap	1992
A randomized trial of ciprofloxacin plus azlocillin versus netilmicin plus azlocillin for the empirical treatment of fever in neutropenic patients. The Journal of antimicrobial chemotherapy, 1991, Volume: 28, Issue:2 Topics: Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gra	1991
Clinical efficacy and in vitro activity of the ciprofloxacin-azlocillin combination (ratio 1:10) against gram-negative bacteria from non-neutropenic haematologic patients. Drugs under experimental and clinical research, 1991, Volume: 17, Issue:9 Topics: Adult; Aged; Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Female; Gram-Negative Bacteria; G	1991

Article	Year
Antimicrobial susceptibilities and clinical sources of Dialister species. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Micro	2007
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial;	2008
In vitro activities of tigecycline against clinical isolates of Aeromonas, Vibrio, and Salmonella species in Taiwan. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Aeromonas; Anti-Bacterial Agents; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; M	2008
Plasmid-mediated QnrS2 determinant from a clinical Aeromonas veronii isolate. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Aeromonas; Ciprofloxacin; Drug Resistance, Bacterial; Genes, Bacterial; Gram-Negative Bacterial Infe	2008
Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10 Topics: Alleles; Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; Chromosomes, Bacterial; DNA Prim	2008
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11 Topics: Base Sequence; beta-Lactam Resistance; beta-Lactamases; Data Collection; DNA Primers; DNA, Bacterial	2008
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Drug Resistance, Bacterial; Ertapenem;	2009
Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Utilization; Gram-Negative Bacteria; Gram-Ne	2010
Microwave assisted synthesis and antimicrobial evaluation of new fused pyran derivatives bearing 2-morpholinoquinoline nucleus. Bioorganic & medicinal chemistry letters, 2011, Oct-15, Volume: 21, Issue:20 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Candida albicans; Fungi; Gram-Negative Bacte	2011
Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections. Journal of medicinal chemistry, 2012, Feb-23, Volume: 55, Issue:4 Topics: Amidohydrolases; Animals; Anti-Bacterial Agents; Crystallography, X-Ray; Gram-Negative Bacteria; Gra	2012
'The Violet Killer'-Successful Treatment of an Infant with Chromobacterium violaceum Sepsis. Journal of tropical pediatrics, 2021, 08-27, Volume: 67, Issue:4 Topics: Anti-Bacterial Agents; Chromobacterium; Ciprofloxacin; Gram-Negative Bacterial Infections; Humans; I	2021
Antimicrobial agents and chemotherapy, 2022, 04-19, Volume: 66, Issue:4 Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans;	2022
Intravenous to oral transition of antibiotics for gram-negative bloodstream infection at a University hospital in Thailand: Clinical outcomes and predictors of treatment failure. PloS one, 2022, Volume: 17, Issue:9 Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Gram-Negative Bacterial Infections; HIV Infections	2022
Induction of Antimicrobial Resistance of Microbial drug resistance (Larchmont, N.Y.), 2023, Volume: 29, Issue:4 Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Gram-Negative Bacteri	2023
Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections. International journal of pharmaceutics, 2020, Feb-15, Volume: 575 Topics: A549 Cells; Administration, Inhalation; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Combina	2020
Journal of wound care, 2020, 01-02, Volume: 29, Issue:1 Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Cefuroxime; Ciprofloxacin; Cloxacillin; D	2020
Successful conservative treatment of necrotizing fasciitis associated with Aeromonas veronii in a patient with acute myeloid leukemia. Medecine et maladies infectieuses, 2020, Volume: 50, Issue:5 Topics: Aeromonas veronii; Aged; Anti-Bacterial Agents; Cefepime; Ciprofloxacin; Combined Modality Therapy;	2020
Francisella novicida and F. philomiragia biofilm features conditionning fitness in spring water and in presence of antibiotics. PloS one, 2020, Volume: 15, Issue:2 Topics: Adaptation, Physiological; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Conserved Sequence; DNA,	2020
Temporal association between carbapenems usage and antimicrobial resistance in gram-negative bacteria at a tertiary hospital in Nanjing, China. Diagnostic microbiology and infectious disease, 2020, Volume: 98, Issue:2 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Ceftazidime; China; Ciprofloxacin; Drug	2020
Antimicrobial resistance and virulence genes profiles of Arcobacter butzleri strains isolated from back yard chickens and retail poultry meat in Chile. Letters in applied microbiology, 2021, Volume: 72, Issue:2 Topics: Animals; Anti-Bacterial Agents; Arcobacter; Chickens; Chile; Ciprofloxacin; Drug Resistance, Bacteri	2021
Reducing Second Gram-Negative Antibiotic Therapy on Pediatric Oncology and Hematopoietic Stem Cell Transplantation Services. Infection control and hospital epidemiology, 2017, Volume: 38, Issue:9 Topics: Adolescent; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactams; Child; Child, Preschool;	2017
Multiple Liver Abscesses with a Skin Pustule due to Chromobacterium violaceum. Internal medicine (Tokyo, Japan), 2017, Sep-15, Volume: 56, Issue:18 Topics: Aged; Anti-Bacterial Agents; Bacteremia; Chromobacterium; Ciprofloxacin; Female; Gram-Negative Bacte	2017
Switchable Control of Antibiotic Activity: A Shape-Shifting "Tail" Strategy. Bioconjugate chemistry, 2018, 01-17, Volume: 29, Issue:1 Topics: Acrylic Resins; Anti-Bacterial Agents; Bacterial Proteins; Biological Transport; Ciprofloxacin; Drug	2018
Leukoerythroblastosis in a Young Child with Severe Malaria and Superimposed Gram Negative Infection. Journal of tropical pediatrics, 2018, 12-01, Volume: 64, Issue:6 Topics: Anemia, Myelophthisic; Antimalarials; Blood Transfusion; Child, Preschool; Ciprofloxacin; Enterobact	2018
Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia. Cornea, 2018, Volume: 37, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Corneal	2018
Septic shock due to meropenem- and colistin-resistant Cupriavidus pauculus. The Journal of hospital infection, 2018, Volume: 99, Issue:3 Topics: Anti-Bacterial Agents; Ciprofloxacin; Colistin; Cupriavidus; Drug Resistance, Bacterial; Drug Therap	2018
Plasmid-Mediated Quinolone Resistance in Gram-Negative Pathogens Isolated from Cancer Patients in Egypt. Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Egypt;	2018
Necrotizing Pneumonia Caused by The American journal of tropical medicine and hygiene, 2018, Volume: 99, Issue:1 Topics: Anti-Bacterial Agents; Child; Chromobacterium; Ciprofloxacin; Female; Gram-Negative Bacterial Infect	2018
Potential pathogenicity of Inquilinus limosus in a pediatric patient with cystic fibrosis. Pediatric pulmonology, 2018, Volume: 53, Issue:7 Topics: Amikacin; Anti-Bacterial Agents; Child; Ciprofloxacin; Clindamycin; Cystic Fibrosis; Gram-Negative B	2018
Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report. BMC pulmonary medicine, 2018, May-29, Volume: 18, Issue:1 Topics: Anti-Bacterial Agents; Ciprofloxacin; Coinfection; Cross Infection; Drug Resistance, Multiple, Bacte	2018
Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections. Journal of controlled release : official journal of the Controlled Release Society, 2018, 10-10, Volume: 287 Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Ciprofloxacin; Delayed-Action Preparatio	2018
Ciprofloxacin prophylaxis during autologous stem cell transplantation for multiple myeloma in patients with a high rate of fluoroquinolone-resistant gram-negative bacteria colonization. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2019, Volume: 163, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Carrier State; Cip	2019
Bacteremia by Chryseobacterium oranimense, A Colistin-Resistant Gram-Negative Bacilli, in an Immunocompetent Pediatric Patient. The Pediatric infectious disease journal, 2019, Volume: 38, Issue:2 Topics: Anti-Bacterial Agents; Autistic Disorder; Bacteremia; Child; Chryseobacterium; Ciprofloxacin; Colist	2019
Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children: A Multicenter Experience. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2019, Volume: 20, Issue:5 Topics: Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Comorbidity; Critical Illness; Drug C	2019
Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria. The Journal of antimicrobial chemotherapy, 2019, 09-01, Volume: 74, Issue:9 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Apoproteins; Ciprofloxacin; Drug Resistance, Bacteri	2019
The role of leech water sampling in choice of prophylactic antibiotics in medical leech therapy. Microsurgery, 2013, Volume: 33, Issue:4 Topics: Aeromonas hydrophila; Amputation, Traumatic; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis;	2013
Otogenic cerebellar abscess by Enterococcus avium, a very rare infectious agent. Journal of neurological surgery. Part A, Central European neurosurgery, 2013, Volume: 74 Suppl 1 Topics: Acetamides; Anti-Bacterial Agents; Brain Abscess; Cerebellar Diseases; Ciprofloxacin; Enterococcus;	2013
A persistent, symptomatic urinary tract infection with multiple "negative" urine cultures. Connecticut medicine, 2013, Volume: 77, Issue:1 Topics: Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Gram-Negative Aerobic Bacteria; Gram-Negati	2013
The management gram-negative bacterial haematogenous vertebral osteomyelitis: a case series of diagnosis, treatment and therapeutic outcomes. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2013, Volume: 22, Issue:8 Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Cohort Studies; Comorbid	2013
Two cases of Kerstersia gyiorum isolated from sites of chronic infection. Journal of clinical microbiology, 2013, Volume: 51, Issue:6 Topics: Alcaligenaceae; Anti-Bacterial Agents; Bacteriological Techniques; Chronic Disease; Ciprofloxacin; D	2013
Bacteremia due to Aeromonas hydrophila in acute lymphoblastic leukemia. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2013, Volume: 23, Issue:12 Topics: Acute Disease; Aeromonas hydrophila; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Female; Fever	2013
Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations. Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:1 Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Infective Agents; Bacteremia; Candidiasis; Child; Chil	2014
Ciprofloxacin-resistant Aeromonas infection following leech therapy for digit replantation: report of 2 cases. The Journal of hand surgery, 2014, Volume: 39, Issue:3 Topics: Adult; Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacteri	2014
Ornamental fish as a source of plasmid-mediated quinolone resistance genes and antibiotic resistance plasmids. Veterinary microbiology, 2014, Jul-16, Volume: 171, Issue:3-4 Topics: Aeromonas; Animals; Anti-Bacterial Agents; Aquaculture; Base Sequence; Blotting, Southern; Carps; Ci	2014
Acute prostatitis caused by Raoultella planticola in a renal transplant recipient: a novel case. Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:3 Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial	2014
Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:11 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthritis; Ciprofloxacin; Debridement; Female; Gram-	2014
Antimicrobial co-resistance patterns of gram-negative bacilli isolated from bloodstream infections: a longitudinal epidemiological study from 2002-2011. BMC infectious diseases, 2014, Oct-12, Volume: 14 Topics: Anti-Bacterial Agents; Bacteremia; British Columbia; Ciprofloxacin; Drug Resistance, Bacterial; Ente	2014
Bacteria causing ventriculoperitoneal shunt infections in a Kenyan population. Journal of neurosurgery. Pediatrics, 2015, Volume: 15, Issue:2 Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Child; Child, Preschool; Chloramphenicol; Ciprofloxac	2015
Microbial keratitis in los angeles: the doheny eye institute and the los angeles county hospital experience. Ophthalmology, 2015, Volume: 122, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Child; Ciprofloxacin; C	2015
Microbiological and clinical features of four cases of catheter-related infection by Methylobacterium radiotolerans. Journal of clinical microbiology, 2015, Volume: 53, Issue:4 Topics: Aged, 80 and over; Anti-Bacterial Agents; Catheter-Related Infections; Child; Ciprofloxacin; Female;	2015
Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China. American journal of infection control, 2015, Apr-01, Volume: 43, Issue:4 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Ceftazidime; China; Ciprofloxacin; Cross Infection;	2015
Impact of Ciprofloxacin and Clindamycin Administration on Gram-Negative Bacteria Isolated from Healthy Volunteers and Characterization of the Resistance Genes They Harbor. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Fece	2015
[Urinary tract infection associated with Delftia acidovorans]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2015, Volume: 28, Issue:6 Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Delftia acidovorans; Drug Resistance, Microbial; Female;	2015
Occurrence and antimicrobial resistance of emergent Arcobacter spp. isolated from cattle and sheep in Iran. Comparative immunology, microbiology and infectious diseases, 2016, Volume: 44 Topics: Abattoirs; Animals; Anti-Bacterial Agents; Arcobacter; Carrier State; Cattle; Cattle Diseases; Cipro	2016
Place of diagnostic tools in the identification of Anaerobiospirillum succiniciproducens bacteraemia. Anaerobe, 2016, Volume: 39 Topics: Anaerobiospirillum; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Clindamycin; Delayed Diagnos	2016
Stenotrophomonas maltophilia biofilm reduction by Bdellovibrio exovorus. Environmental microbiology reports, 2016, Volume: 8, Issue:3 Topics: Anti-Bacterial Agents; Antibiosis; Bdellovibrio; Biofilms; Ciprofloxacin; Environmental Microbiology	2016
Shewanella algae bacteremia from a foot ulcer exposed to seawater during a Caribbean vacation. Journal of travel medicine, 2016, Volume: 23, Issue:3 Topics: Aged; Anti-Bacterial Agents; Bacteremia; Caribbean Region; Ciprofloxacin; Diabetes Mellitus, Type 2;	2016
[Antimicrobial susceptibility of Gram-negative bacilli of community acquired intra-abdominal infections in a hospital at Buenos Aires, Argentina]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2016, Volume: 29, Issue:4 Topics: Abdomen; Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Argentina; Ciprofloxacin; Commu	2016
Antimicrobial Stewardship in the Microbiology Laboratory: Impact of Selective Susceptibility Reporting on Ciprofloxacin Utilization and Susceptibility of Gram-Negative Isolates to Ciprofloxacin in a Hospital Setting. Journal of clinical microbiology, 2016, Volume: 54, Issue:9 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Utilization; Gram-Negative Ba	2016
Drug Susceptibility Assessment in Stenotrophomonas Maltophilia Strains Isolated From the Blood of Organ Transplantation Recipients in a Warsaw Teaching Hospital During 2011 to 2014. Transplantation proceedings, 2016, Volume: 48, Issue:5 Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clavulanic Acids; Drug Resistance, Bacterial; Gra	2016
Plasmid-mediated quinolone resistance determinants among Gram-negative bacteraemia isolates: a hidden threat. Journal of medical microbiology, 2017, Volume: 66, Issue:3 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV;	2017
Antibiotic Sensitivity pattern of Bacterial Isolates of Neonatal Septicemia in Peshawar, Pakistan. Archives of Iranian medicine, 2016, Volume: 19, Issue:12 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacteri	2016
Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis. Journal of pediatric hematology/oncology, 2017, Volume: 39, Issue:3 Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Child;	2017
Stenotrophomonas maltophilia isolated from prostatic fluid as an infertility factor in a male dog. Andrologia, 2017, Volume: 49, Issue:10 Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Dog Diseases; Dogs; Gram-Negative Bacterial Infection	2017
Investigation of plasmid-mediated quinolone resistance among isolates obtained in a Turkish intensive care unit. Japanese journal of infectious diseases, 2008, Volume: 61, Issue:4 Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Gram-Negative	2008
Post-operative endophthalmitis due to an unusual pathogen, Comamonas testosteroni. Journal of medical microbiology, 2009, Volume: 58, Issue:Pt 3 Topics: Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Ceftazidime; Ciprofloxacin; Comamonas	2009
[Non necrotizing bacterial cellulitis and bacteriemia due to Shewanella putrefaciens]. La Revue de medecine interne, 2009, Volume: 30, Issue:9 Topics: Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Ceftriaxone; Cellulitis	2009
Ochrobactrum anthropi septic arthritis of the acromioclavicular joint in an immunocompetent 17 year old. Orthopedics, 2008, Volume: 31, Issue:6 Topics: Acromioclavicular Joint; Adolescent; Anti-Infective Agents; Arthritis, Infectious; Arthroplasty; Cip	2008
Chromobacterium violaceum endocarditis and hepatic abscesses treated successfully with meropenem and ciprofloxacin. The Medical journal of Australia, 2009, Apr-06, Volume: 190, Issue:7 Topics: Adult; Aortic Valve; Chromobacterium; Ciprofloxacin; Drug Therapy, Combination; Echocardiography, Tr	2009
Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections. International journal of antimicrobial agents, 2009, Volume: 34, Issue:3 Topics: Anti-Infective Agents; Argentina; Biofilms; Ciprofloxacin; Cross Infection; Drug Resistance, Multipl	2009
[Leech-borne infection on a TRAM flap: a case report]. Annales de chirurgie plastique et esthetique, 2010, Volume: 55, Issue:1 Topics: Aeromonas hydrophila; Cephalosporins; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Hum	2010
Chromobacterium violaceum endocarditis and hepatic abscesses treated successfully with meropenem and ciprofloxacin. The Medical journal of Australia, 2009, Oct-05, Volume: 191, Issue:7 Topics: Anti-Bacterial Agents; Chromobacterium; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bact	2009
The effects of ciprofloxacin and ursodeoxycholic acid on bacterial translocation in obstructive jaundice. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2009, Volume: 20, Issue:3 Topics: Animals; Anti-Infective Agents; Bacterial Translocation; Cholagogues and Choleretics; Ciprofloxacin;	2009
Ecological effects of selective decontamination on resistant gram-negative bacterial colonization. American journal of respiratory and critical care medicine, 2010, Mar-01, Volume: 181, Issue:5 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftazidime; Ciprofloxacin; Cross Infection; Drug Res	2010
Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia. Journal of the European Academy of Dermatology and Venereology : JEADV, 2010, Volume: 24, Issue:8 Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Age	2010
Treatment of Stenotrophomonas neonatal urinary tract infection with instillation of ciprofloxacin. Pediatric nephrology (Berlin, Germany), 2010, Volume: 25, Issue:7 Topics: Anti-Infective Agents; Ciprofloxacin; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; M	2010
Quinolone-resistant Aeromonas hydrophila peritonitis in a CAPD patient. Clinical nephrology, 2010, Volume: 73, Issue:3 Topics: Adult; Aeromonas hydrophila; Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Drug Resistance, Bac	2010
The impact of fluoroquinolones use on antibiotic resistance in an intensive care burn department. La Tunisie medicale, 2010, Volume: 88, Issue:5 Topics: Acinetobacter; Anti-Infective Agents; Burn Units; Ceftazidime; Ciprofloxacin; Drug Resistance, Multi	2010
Infection caused by Rahnella aquatilis. The American journal of the medical sciences, 2010, Volume: 339, Issue:6 Topics: Adult; Anemia, Sickle Cell; Anti-Bacterial Agents; Catheterization, Central Venous; Ciprofloxacin; E	2010
In vitro ciprofloxacin resistance profiles among gram-negative bacteria isolated from clinical specimens in a teaching hospital. JPMA. The Journal of the Pakistan Medical Association, 2010, Volume: 60, Issue:8 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negat	2010
[Ochrobactrum anthropi and polymicrobial peritonitis in peritoneal dialysis: a resistance predictor]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2010, Volume: 30, Issue:5 Topics: Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug	2010
In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2 Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Diarrhea; Drug Resistance, Ba	2011
Late-onset intrascleral dissemination of Stenotrophomonas maltophilia scleritis after pterygium excision. Cornea, 2011, Volume: 30, Issue:6 Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Debridement; Eye Infections, Bacterial; Female; Gram-Neg	2011
Leech-transmitted ciprofloxacin-resistant Aeromonas hydrophila. Archives of otolaryngology--head & neck surgery, 2011, Volume: 137, Issue:2 Topics: Aeromonas hydrophila; Animals; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistanc	2011
Patterns of ciprofloxacin-resistant gram-negative bacteria colonization in nursing home residents. Infection control and hospital epidemiology, 2011, Volume: 32, Issue:2 Topics: Anti-Infective Agents; Carrier State; Ciprofloxacin; Cognition Disorders; Comorbidity; Cross-Section	2011
Nonpigmented Chromobacterium violaceum bacteremic cellulitis after fish bite. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2011, Volume: 44, Issue:5 Topics: Anti-Bacterial Agents; Bacteremia; Bacteriological Techniques; Bites and Stings; Cellulitis; Chromob	2011
Comamonas testosteroni infection in Taiwan: Reported two cases and literature review. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2011, Volume: 44, Issue:1 Topics: Aged; Alcoholism; Anti-Bacterial Agents; Bacteremia; Carcinoma, Hepatocellular; Cellulitis; Cephalos	2011
Optimizing ciprofloxacin dosing in intensive care unit patients through the use of population pharmacokinetic-pharmacodynamic analysis and Monte Carlo simulations. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:8 Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciproflo	2011
Ciprofloxacin use and susceptibility of Gram-negative organisms to quinolone and non-quinolone antibiotics. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:9 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Utilization; Gram-Negative Bacteria; Gram-Negative Bacter	2011
Enhancement of antibiotic susceptibility of Stenotrophomonas maltophilia using a polyclonal antibody developed against an ABC multidrug efflux pump. Canadian journal of microbiology, 2011, Volume: 57, Issue:10 Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; ATP-Binding Cassette Transporters; Ciprofloxa	2011
Expression of Sme efflux pumps and multilocus sequence typing in clinical isolates of Stenotrophomonas maltophilia. Annals of laboratory medicine, 2012, Volume: 32, Issue:1 Topics: Alleles; Anti-Infective Agents; Bacterial Proteins; Bacterial Typing Techniques; Ciprofloxacin; Drug	2012
Photo quiz: A 36-year-old with recurrent conjunctivitis. Journal of clinical microbiology, 2012, Volume: 50, Issue:2 Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Aza Compounds; Bacterial Typing Techniques; B	2012
Ceftriaxone and ciprofloxacin restriction in an intensive care unit: less incidence of Acinetobacter spp. and improved susceptibility of Pseudomonas aeruginosa. Revista panamericana de salud publica = Pan American journal of public health, 2011, Volume: 30, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Ceftriaxone; Ciprofloxacin; Cross In	2011
[Neonatal infection with Stenotrophomonas maltophilia (2 case studies)]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2012, Volume: 19, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; Brain Abscess; Chloramphenicol; Ciprofloxacin; Cross Infection; Dru	2012
[A rare cause of pneumonia: Shewanella putrefaciens]. Mikrobiyoloji bulteni, 2012, Volume: 46, Issue:1 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bronchiectasis; Ceftazidime; Ceftriaxone; Cipro	2012
[In vitro antibiotic susceptibility to fluoroquinolones]. Archivos de la Sociedad Espanola de Oftalmologia, 2012, Volume: 87, Issue:3 Topics: Acanthamoeba Keratitis; Anti-Bacterial Agents; Aza Compounds; Body Fluids; Ciprofloxacin; Colombia;	2012
Bacteriological agents of chronic discharging ears and their antibiotic sensitivity pattern in Ido - Ekiti, Nigeria. The Nigerian postgraduate medical journal, 2012, Volume: 19, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Child; C	2012
Arcobacter species in diarrhoeal faeces from humans in New Zealand. The New Zealand medical journal, 2012, Apr-20, Volume: 125, Issue:1353 Topics: Adult; Aged; Ampicillin; Arcobacter; Child, Preschool; Ciprofloxacin; Diarrhea; Erythromycin; Feces;	2012
Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PloS one, 2012, Volume: 7, Issue:5 Topics: Aged; Ciprofloxacin; Colistin; Colony Count, Microbial; Cross Infection; Drug Resistance, Multiple,	2012
Cutaneous abscess leading to sepsis by Aeromonas hydrophila. Infection, 2013, Volume: 41, Issue:2 Topics: Abscess; Aeromonas hydrophila; Cefepime; Cephalosporins; Ciprofloxacin; Fever; Gram-Negative Bacteri	2013
Coordinate hyperproduction of SmeZ and SmeJK efflux pumps extends drug resistance in Stenotrophomonas maltophilia. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Ciprofloxacin; Gene Expression; Genes,	2013
Comparison of E-test with other conventional susceptibility testing methods for ciprofloxacin and gentamicin against gram negative enteric bacilli. African journal of medicine and medical sciences, 2012, Volume: 41, Issue:2 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteri	2012
Ciprofloxacin-resistant Aeromonas hydrophila cellulitis following leech therapy. Journal of clinical microbiology, 2013, Volume: 51, Issue:4 Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Cellulitis; Child; Ciprofloxacin; Drug Resista	2013
Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:6 Topics: Anti-Bacterial Agents; Bacteremia; Cancer Care Facilities; Ciprofloxacin; Drug Resistance, Bacterial	2013
Clinical presentation of microbial keratitis with daily wear frequent-replacement hydrogel lenses: a case series. The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc, 2002, Volume: 28, Issue:3 Topics: Adolescent; Adult; Aeromonas; Anti-Infective Agents; Ciprofloxacin; Contact Lenses, Hydrophilic; Eye	2002
Evidence of cross-resistance between ciprofloxacin and non-fluoroquinolones in European Gram-negative clinical isolates. The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:3 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Europe; Gram-Negative Ba	2002
Successful treatment of multi-resistant Stenotrophomonas maltophilia meningitis with ciprofloxacin in a pre-term infant. European journal of pediatrics, 2002, Volume: 161, Issue:12 Topics: Anti-Infective Agents; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Humans; Infant, Ne	2002
Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA, 2003, Feb-19, Volume: 289, Issue:7 Topics: Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Utilization;	2003
[Bacterial resistance to antibiotics in gram-negative rods isolated from intensive care units. Comparative analysis between two periods (1998 and 2001)]. Medicina, 2003, Volume: 63, Issue:1 Topics: Acinetobacter; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Age	2003
In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7 Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Cefotaxi	2003
Isolation and antimicrobial susceptibility of Aeromonas salmonicida in rainbow trout (Oncorhynchus mykiss) in turkey hatchery farms. Journal of veterinary medicine. B, Infectious diseases and veterinary public health, 2003, Volume: 50, Issue:7 Topics: Aeromonas; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Fish Diseases;	2003
[Necrotizing otitis externa caused by Stenotrophomonas maltophilia]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:11 Topics: Anti-Infective Agents; Bacteriological Techniques; Biopsy; Ciprofloxacin; Cross Infection; Dose-Resp	2003
Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome. Bone marrow transplantation, 2004, Volume: 33, Issue:3 Topics: Adolescent; Adult; Antibiotic Prophylaxis; Bacteremia; Bone Marrow Transplantation; Case-Control Stu	2004
Bacteriobilia in percutaneous transhepatic biliary drainage: occurrence over time and clinical sequelae. A prospective observational study. Scandinavian journal of gastroenterology, 2003, Volume: 38, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bile Ducts, Intrahepatic; Biliary Tract Surgi	2003
Cardiobacterium hominis endocarditis associated with very severe thrombocytopenia and platelet autoantibodies. American journal of hematology, 2004, Volume: 76, Issue:4 Topics: Ampicillin; Antigens, Human Platelet; Aortic Valve Stenosis; Autoantibodies; Autoimmune Diseases; Ba	2004
An unusually high level of quinolone resistance associated with type II topoisomerase mutations in quinolone resistance-determining regions of Aeromonas caviae isolated from diarrhoeal patients. Research in microbiology, 2004, Volume: 155, Issue:10 Topics: Aeromonas; Anti-Infective Agents; Base Sequence; Ciprofloxacin; Diarrhea; DNA Gyrase; DNA Topoisomer	2004
Comparison of in vitro susceptibilities to levofloxacin and ciprofloxacin with Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients in Northern Ireland. British journal of biomedical science, 2005, Volume: 62, Issue:1 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Child; Ciprofloxacin; Cystic Fibrosis; Female;	2005
Differences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two Italian centres. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Child; Ciprofloxacin; Drug Resistance, Mul	2005
Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens. Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteri	2005
Aeromonas veronii biovar sobria bacteraemia with septic arthritis confirmed by 16S rDNA PCR in an immunocompetent adult. Journal of medical microbiology, 2006, Volume: 55, Issue:Pt 2 Topics: Aeromonas; Aged, 80 and over; Anti-Infective Agents; Arthritis, Infectious; Bacteremia; Ciprofloxaci	2006
Bacteraemia in cancer patients caused by colistin-resistant Gram-negative bacilli after previous exposure to ciprofloxacin and/or colistin. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12, Issue:5 Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Gram-Negativ	2006
Effectiveness of flouroquinolone therapy for gram-negative infections within the intensive care unit setting. The American journal of medicine, 2006, Volume: 119, Issue:6 Topics: Acinetobacter; Alabama; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacter cloacae; Escherichia	2006
Post-ERCP bacteremia caused by Alcaligenes xylosoxidans in a patient with pancreas cancer. Annals of clinical microbiology and antimicrobials, 2006, Sep-01, Volume: 5 Topics: Aged; Alcaligenes; Anti-Infective Agents; Bacteremia; Cholangiopancreatography, Endoscopic Retrograd	2006
Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime-fluoroquinolone combination. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bone Diseases, Infectious; Cefepime; Cephalos	2006
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model. Chemotherapy, 2006, Volume: 52, Issue:6 Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination;	2006
Prevalence of multiresistant Gram-negative organisms in a surgical hospital in Ho Chi Minh City, Vietnam. Tropical medicine & international health : TM & IH, 2006, Volume: 11, Issue:11 Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Ciprofloxacin; Cross Infection; Dr	2006
Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis. International journal of antimicrobial agents, 2007, Volume: 29, Issue:1 Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Carbapenems; Cefe	2007
Pyrosequencing of the DNA gyrase gene in Neisseria species: effective indicator of ciprofloxacin resistance in Neisseria gonorrhoeae. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2006, Volume: 114, Issue:12 Topics: Amino Acid Sequence; Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA Gyrase; DNA, Bacterial	2006
Risk factors associated with resistance to ciprofloxacin in clinical bacterial isolates from intensive care unit patients. Infection control and hospital epidemiology, 2007, Volume: 28, Issue:3 Topics: Adult; Aged; Anti-Infective Agents; Canada; Ciprofloxacin; Cohort Studies; Drug Resistance, Bacteria	2007
Nucleotide sequence of the gyrA gene of Arcobacter species and characterization of human ciprofloxacin-resistant clinical isolates. FEMS immunology and medical microbiology, 2007, Volume: 49, Issue:3 Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Arcobacter; Base Sequence; Camp	2007
[In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens]. Le infezioni in medicina, 2006, Volume: 14, Issue:1 Topics: Anti-Bacterial Agents; Ciprofloxacin; Dioxolanes; Drug Resistance, Multiple, Bacterial; Fluoroquinol	2006
Stenotrophomonas maltophilia infection of the central venous catheter and lysis of an old thrombosis in a post-bone marrow transplantation child: implications in the fibrinolytic process. Scandinavian journal of infectious diseases, 2007, Volume: 39, Issue:4 Topics: Amikacin; Bacteriolysis; Bone Marrow Transplantation; Catheterization, Central Venous; Child; Ciprof	2007
Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit. The Journal of trauma, 2007, Volume: 63, Issue:2 Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clinical Protocols; Critical Care; Cross Infectio	2007
Plasma thrombin activatable fibrinolysis inhibitor and tissue factor pathway inhibitor changes following sepsis. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2007, Volume: 13, Issue:4 Topics: Animals; Carboxypeptidase B2; Ciprofloxacin; Enterococcus faecalis; Gram-Negative Bacterial Infectio	2007
Antimicrobial resistance in clinical isolates of Neisseria subflava from the oral cavities of a Japanese population. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2007, Volume: 13, Issue:5 Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; F	2007
A possible new cause of spa bath folliculitis: Aeromonas hydrophila. The Australasian journal of dermatology, 2008, Volume: 49, Issue:1 Topics: Adult; Aeromonas hydrophila; Alopecia; Anti-Bacterial Agents; Cicatrix; Ciprofloxacin; Filtration; F	2008
Posttraumatic Stenotrophomonas maltophilia infectious scleritis. Cornea, 2008, Volume: 27, Issue:2 Topics: Ciprofloxacin; Combined Modality Therapy; Conjunctiva; Drug Therapy, Combination; Eye Foreign Bodies	2008
Experience of Comamonas acidovorans keratitis with delayed onset and treatment response in immunocompromised cornea. Korean journal of ophthalmology : KJO, 2008, Volume: 22, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Corneal Ulcer; Delftia acidovorans; Dru	2008
Meningitis caused by Alcaligenes xylosoxidans in a patient with HIV/AIDS. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2007, Volume: 11, Issue:6 Topics: AIDS-Related Opportunistic Infections; Alcaligenes; Anti-Infective Agents; Ciprofloxacin; Gram-Negat	2007
Trends in resistance to ciprofloxacin, cefazolin, and gentamicin in the treatment of bacterial keratitis. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008, Volume: 24, Issue:2 Topics: Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Drug Resistance, Bacterial; Eye Infections, Bacteri	2008
Aeromonas hydrophila bacteraemia and portal pyaemia. Singapore medical journal, 2008, Volume: 49, Issue:4 Topics: Aeromonas hydrophila; Aged; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Gram-Negative Bacteria	2008
Fluoroquinolone resistance during 2000-2005: an observational study. BMC infectious diseases, 2008, May-24, Volume: 8 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Community-Acquired Infec	2008
Chronic diarrhea due to a single strain of Aeromonas caviae. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1995, Volume: 14, Issue:1 Topics: Aeromonas; Chronic Disease; Ciprofloxacin; Diarrhea; DNA, Bacterial; Feces; Gram-Negative Bacterial	1995
Multicenter Spanish study of ciprofloxacin susceptibility in gram-negative bacteria. The Spanish Study Group on Quinolone Resistance. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1995, Volume: 14, Issue:5 Topics: Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bac	1995
Fluoroquinolones for the eye. Drug and therapeutics bulletin, 1994, Oct-20, Volume: 32, Issue:10 Topics: Chloramphenicol; Ciprofloxacin; Eye Infections, Bacterial; Gram-Negative Bacterial Infections; Human	1994
[The efficacy of the clinical use of the preparation Cifran in treating surgical infection]. Klinicheskaia khirurgiia, 1994, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Drug Evaluation; Female; Fluor	1994
[Antibiotic treatment for pneumonia caused by Flavobacterium meningosepticum]. Zhonghua nei ke za zhi, 1994, Volume: 33, Issue:9 Topics: Aged; Aztreonam; Cefsulodin; Ciprofloxacin; Drug Therapy, Combination; Female; Flavobacterium; Gram-	1994
Pharmacokinetics of ciprofloxacin in ponies. Journal of veterinary pharmacology and therapeutics, 1995, Volume: 18, Issue:1 Topics: Administration, Oral; Animals; Aqueous Humor; Biological Availability; Ciprofloxacin; Computer Simul	1995
Antibacterial efficacy of ciprofloxacin in a case of endocarditis due to Cardiobacterium hominis. Zentralblatt fur Bakteriologie : international journal of medical microbiology, 1994, Volume: 281, Issue:1 Topics: Adult; Bacteria, Anaerobic; Blood Bactericidal Activity; Ciprofloxacin; Endocarditis, Bacterial; Gra	1994
Prevalence of ciprofloxacin resistance in multiresistant gram-negative intensive care unit isolates. Infection, 1994, Volume: 22 Suppl 2 Topics: Ciprofloxacin; Cross Infection; Drug Resistance, Multiple; Gram-Negative Bacterial Infections; Human	1994
Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study. Diagnostic microbiology and infectious disease, 1994, Volume: 19, Issue:1 Topics: beta-Lactamases; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Cro	1994
Prevention of bacteraemia by systemic ciprofloxacin treatment in rat cytomegalovirus-infected immunocompromised rats. The Journal of antimicrobial chemotherapy, 1994, Volume: 34, Issue:1 Topics: Animals; Bacteremia; Ciprofloxacin; Cytomegalovirus Infections; Gram-Negative Aerobic Bacteria; Gram	1994
Wound infection due to Aeromonas sobria. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17, Issue:6 Topics: Adult; Aeromonas; Ciprofloxacin; Gram-Negative Bacterial Infections; Humans; Male; Water Microbiolog	1993
Pseudoinfection of a total knee arthroplasty. Infection control and hospital epidemiology, 1994, Volume: 15, Issue:3 Topics: Aged; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Humans; Knee Prosthesis; Prosthesis	1994
Sequential intravenous/oral ciprofloxacin in the treatment of severe multiresistant gram-negative infections. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1993, Volume: 76, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Ciprofloxacin; Drug Resistance, Microbial; Female; Gram-Neg	1993
Activity of imipenem, third-generation cephalosporins, aztreonam and ciprofloxacin against multi-resistant gram-negative bacilli isolated from Chilean hospitals. The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:3 Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Chile; Ciprofloxacin; Cross Infection; Drug Resist	1993
Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1994, Mar-01, Volume: 150, Issue:5 Topics: Administration, Oral; Ciprofloxacin; Diarrhea; Gram-Negative Bacterial Infections; Humans; Respirato	1994
The new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patients. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A Suppl 1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Gram-Negativ	1993
Increased resistance to quinolone in Catalonia, Spain. Diagnostic microbiology and infectious disease, 1993, Volume: 16, Issue:2 Topics: Anti-Infective Agents; Campylobacter Infections; Ciprofloxacin; Drug Resistance, Microbial; Enteroba	1993
The treatment of neonatal meningitis due to gram-negative bacilli with ciprofloxacin: evidence of satisfactory penetration into the cerebrospinal fluid. The Journal of infection, 1993, Volume: 26, Issue:3 Topics: Ciprofloxacin; Escherichia coli Infections; Flavobacterium; Gram-Negative Bacterial Infections; Huma	1993
Comparison of susceptibility to extended-spectrum beta-lactam antibiotics and ciprofloxacin among gram-negative bacilli isolated from intensive care units. Diagnostic microbiology and infectious disease, 1995, Volume: 22, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Res	1995
Bacteremic necrotizing fasciitis due to Flavobacterium odoratum. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 21, Issue:5 Topics: Aged; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Drug Resistance, Multiple; Fasciitis, Necrot	1995
Antibiotic prophylaxis of ERCP with ciprofloxacin. Gastrointestinal endoscopy, 1996, Volume: 43, Issue:2 Pt 1 Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Cholangiopancreatography, Endoscopic Retrograde; Chol	1996
Ochrobactrum anthropi endophthalmitis after uncomplicated cataract surgery. American journal of ophthalmology, 1996, Volume: 122, Issue:2 Topics: Aged; Alcaligenes; Anterior Chamber; Anti-Infective Agents; Cataract Extraction; Ciprofloxacin; Endo	1996
Treatment of CAPD-related peritonitis with ciprofloxacin: results after seven years. Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 1996, Volume: 12 Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Gram-Negative Bacterial Infections; Gram	1996
Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin;	1996
Severe knee arthritis due to Eikenella corrodens following a human bite. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:1 Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Arthritis, I	1997
[Gram-negative bacilli isolated in a general hospital: high rate of ciprofloxacin resistance]. Enfermedades infecciosas y microbiologia clinica, 1996, Volume: 14, Issue:4 Topics: Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative	1996
Endogenous Ochrobactrum anthropi endophthalmitis. American journal of ophthalmology, 1997, Volume: 123, Issue:4 Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Catheterization, Central Venous; Cat	1997
Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:12 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Clavulani	1996
Fluoroquinolone prophylaxis for the prevention of bacterial infections in patients with cancer--is it justified? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 25, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Therapy; Ent	1997
Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. American journal of respiratory and critical care medicine, 1997, Volume: 156, Issue:4 Pt 1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Ceftazidime; Cephalos	1997
Successful treatment of Edwardsiella tarda prosthetic valve endocarditis in a patient with AIDS. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 25, Issue:4 Topics: Adult; AIDS-Related Opportunistic Infections; Ampicillin; Cefotaxime; Ciprofloxacin; Drug Therapy, C	1997
A case of Plesiomonas shigelloides cellulitis and bacteraemia from northern Europe. Scandinavian journal of infectious diseases, 1997, Volume: 29, Issue:6 Topics: Aged; Anti-Infective Agents; Bacteremia; Cellulitis; Ciprofloxacin; Europe; Gram-Negative Bacterial	1997
Sensitivity pattern and beta-lactamase production in clinical isolates of Aeromonas strains. JPMA. The Journal of the Pakistan Medical Association, 1998, Volume: 48, Issue:6 Topics: Aeromonas; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cephalosporins	1998
Low-level colonization and infection with ciprofloxacin-resistant gram-negative bacilli in a skilled nursing facility. American journal of infection control, 1998, Volume: 26, Issue:6 Topics: Aged; Anti-Infective Agents; California; Carrier State; Ciprofloxacin; Drug Resistance, Microbial; F	1998
Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1999, Volume: 18, Issue:4 Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Aerobic; Ciprofloxacin; Fluoroquinolones; Gram-Negat	1999
Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin. The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:5 Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; G	1999
Infective endocarditis complicated with progressive heart failure due to beta-lactamase-producing Cardiobacterium hominis. Journal of clinical microbiology, 2000, Volume: 38, Issue:5 Topics: Aged; Aortic Valve; Aortic Valve Insufficiency; beta-Lactamases; Ceftriaxone; Ciprofloxacin; Endocar	2000
In vitro activity of difloxacin against canine bacterial isolates. Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc, 2000, Volume: 12, Issue:3 Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dog Diseases; Dogs; Dose-Response Relationship, Drug;	2000
Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology, 2000, Volume: 107, Issue:8 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Cornea; Corneal Ulcer; Drug R	2000
Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. American journal of respiratory and critical care medicine, 2000, Volume: 162, Issue:3 Pt 1 Topics: Aged; Antibiotic Prophylaxis; Ceftazidime; Ciprofloxacin; Critical Care; Cross Infection; Cross-Sect	2000
Aeromonas hydrophila infection secondary to an electrical burn. The Medical journal of Australia, 2000, Aug-21, Volume: 173, Issue:4 Topics: Aeromonas hydrophila; Aged; Anti-Infective Agents; Burns, Electric; Ciprofloxacin; Female; Gentamici	2000
[Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies]. Schweizerische medizinische Wochenschrift, 2000, Dec-02, Volume: 130, Issue:48 Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infections; Ciprofloxacin; Dru	2000
Comamonas acidovorans keratitis in a hydrogel contact lens wearer. The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc, 2001, Volume: 27, Issue:1 Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Contact Lenses, Extended-Wear; Delftia acidovorans; Eye	2001
Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2001, Volume: 20, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Ciprofloxacin; Col	2001
Successful treatment of an infant with Chromobacterium violaceum sepsis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Mar-15, Volume: 32, Issue:6 Topics: Anti-Bacterial Agents; Chromobacterium; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; H	2001
Aeromonas sobria sepsis in a neutropenic patient. Haematologica, 2001, Volume: 86, Issue:4 Topics: Acute Disease; Aeromonas; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxaci	2001
Upper airway obstruction due to rhinoscleroma: case report. Journal of chemotherapy (Florence, Italy), 2001, Volume: 13 Suppl 1 Topics: Airway Obstruction; Anti-Infective Agents; Bronchoscopy; Ciprofloxacin; Dyspnea; Female; Gram-Negati	2001
Opportunistic Roseomonas keratitis. Cornea, 2001, Volume: 20, Issue:7 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Eye Infections, Bacterial; Female; Gr	2001
Pyoderma faciale: gram-negative recovery by means of needle aspiration. Cutis, 2002, Volume: 69, Issue:4 Topics: Adolescent; Anti-Infective Agents; Ciprofloxacin; Cloxacillin; Drainage; Enterobacter cloacae; Facia	2002
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections. Diagnostic microbiology and infectious disease, 2002, Volume: 43, Issue:2 Topics: Aerobiosis; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial	2002
Penetration of ciprofloxacin into human peritoneal tissue following a single oral dose of 750 milligrams. Journal of chemotherapy (Florence, Italy), 1992, Volume: 4, Issue:1 Topics: Abdomen; Administration, Oral; Adult; Aged; Animals; Ciprofloxacin; Cricetinae; Female; Gram-Negativ	1992
[In vitro activity of various antibiotic agents against gram-negative nosocomial bacteremia pathogens]. Mikrobiyoloji bulteni, 1992, Volume: 26, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria;	1992
Treatment of symptomatic enteric aeromonas hydrophila infection with ciprofloxacin. Scandinavian journal of infectious diseases, 1991, Volume: 23, Issue:5 Topics: Aeromonas hydrophila; Aged; Aged, 80 and over; Ciprofloxacin; Disease Outbreaks; Female; Gastroenter	1991

Intervention	Participants (Count of Participants)
Probiotic	8
Standard of Care	8